CVE-2024-43959

WordPress Super Testimonials plugin <= 4.0.1 - Reflected Cross Site Scripting (XSS) vulnerability

7.1 High

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Themepoints Testimonials super-testimonial allows Reflected XSS.This issue affects Testimonials: from n/a through <= 4.0.1.

Attack profile

How easy it is to exploit

Attack vector: Network
Complexity: Low
Privileges needed: None
User interaction: Required

What an attacker can affect

Confidentiality: Low
Integrity: Low
Availability: Low

Exploit likelihood

0.30%Up 0.3 points since Sep 26, 2024

What each source reports

CVE List Score used 7.1

WordPress Super Testimonials plugin <= 4.0.1 - Reflected Cross Site Scripting (XSS) vulnerability

Record: CVE-2024-43959
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Weakness: CWE-79
Updated: 2026-11-02

EUVDEUVD-2024-40608 7.1

Record: EUVD-2024-40608
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Updated: 2026-11-02

GitHub AdvisoriesGHSA-fffw-jm62-gx8w 7.1

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting')...

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Themepoints Testimonials allows Reflected XSS.This issue affects Testimonials: from n/a through 3.0.8.

Record: GHSA-fffw-jm62-gx8w
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Weakness: CWE-79
Updated: 2026-11-02

NVD 7.1

Record: CVE-2024-43959
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Weakness: CWE-79
Updated: 2026-11-02

Affected products

History

History
Recorded	Changed	Sources
Nov 2, 2026	first indexed	CVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2024-43959 is a high vulnerability (CVSS 7.1) in Themepoints Testimonials, published September 25, 2024. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.30%, the 22nd percentile. No source names a fixed version.